Marker Therapeutics (MRKR) Receivables (2022 - 2025)
Marker Therapeutics (MRKR) reported Receivables of $800000.0 for Q3 2025, up 100.0% year-over-year from $400000.0 in Q3 2024, and down 73.1% quarter-over-quarter from $3.0 million in Q2 2025.
Marker Therapeutics (MRKR) Receivables (2022 - 2025) Analysis & Trends
Marker Therapeutics (MRKR) has 4 years of Receivables data on file, last reported at $800000.0 in Q3 2025.
- Receivables for Q3 2025 came in at $800000.0, up 100.0% year-over-year; the trailing twelve-month figure through Sep 2025 was $800000.0 (up 100.0% YoY), and the FY2024 annual result was $11.8 million, up 1588.08% from the prior year.
- Receivables slipped to $800000.0 in Q3 2025 per MRKR's latest filing, from $3.0 million in the prior quarter.
- Over five years, Receivables peaked at $8.0 billion in Q1 2025 and troughed at $400000.0 in Q3 2024.
- A 4-year average of $730.5 million and a median of $3.0 million in 2023 frame the typical range for Receivables.
- The sharpest annual moves came in 2024 and 2025: Receivables tumbled 39.06% in 2024, then jumped 262144.79% in 2025.
- A 4-year view of Receivables shows it stood at $3.7 million in 2022, then slumped by 58.49% to $1.5 million in 2023, then surged by 673.43% to $11.8 million in 2024, then sank by 93.23% to $800000.0 in 2025.
- Business Quant data shows MRKR's Receivables at $800000.0 in Q3 2025, $3.0 million in Q2 2025, and $8.0 billion in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 2.97 Mn |
| Mar 31, 2025 | 8.00 Bn |
| Dec 31, 2024 | 11.82 Mn |
| Sep 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 2.10 Mn |
| Mar 31, 2024 | 3.05 Mn |
| Dec 31, 2023 | 1.53 Mn |
| Jun 30, 2023 | 3.45 Mn |
| Mar 31, 2023 | 3.00 Mn |
| Sep 30, 2022 | 3.68 Mn |